Nitric oxide donors capable of reducing toxicity from drugs

Details Nitric oxide donors capable of reducing toxicity from drugs Nitric oxide donors capable of reducing toxicity from drugs

2006-08-08

2006-08-08

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S165000, C514S169000, C514S200000, C514S788000

Reexamination Certificate

active

07087588

ABSTRACT:
Use of organic compounds containing the —ONO2function, or inorganic compound containing the —NO group or compositions comprising said compounds to reduce the toxicity caused by drugs to the gastrointestinal and/or renal apparatus, said compounds being characterized in that they are nitric oxide NO donors i.e., when they are put into contact in vitro with cells of the vasal endothelium or platelets.

REFERENCES:
patent: 5620416 (1997-04-01), Riviere
patent: 5703073 (1997-12-01), Garvey et al.
patent: WO 94/04484 (1994-03-01), None
patent: WO 94/12463 (1994-06-01), None
patent: WO 95/09831 (1995-04-01), None
patent: WO 95/26768 (1995-10-01), None
patent: WO 95/30641 (1995-11-01), None
patent: WO-A-96/32946 (1996-10-01), None
McNaughton, Life Sci, vol. 45, 1869-1876 (1989).
Kitagawa, Pharm Expt Ther 1133-1137 (1990).
Konturek, Europ J Pharmacol 239 215-217 (1993).
Wallace, J. Gastroent Hepatol 9 S40-S44 (1994).
Barrachina, Europ J Pharmacol 281 R3-R4 (1995).
Wallace, Pulmonary-Allergy Dermat., Gastroint. & Arth., Sect. Rev. 9 613-619 (1995).
Johnstone, J Am. College Card. 145A (1989).
Boughton-Smith, Eur J Pharmacol 191 485-488 (1990).
Brown, Eur J Pharmacol 223 103-104 (1992).
Wallace, Gastroenterol. 173-179 (1994).
Wallace, Eur J. Pharmacol 257, 249-255 (1994).
Elliott, Gastroent., 524-530 (1995).
Wallace, J. Clin. Invest. 96, 2711-2718 (1995).
Wallace, Eur J. Pharmacol 280, 63-68 (1995).
Cuzzolin, Pharmacol. Res. 31, 61-65 (1995).
Rivas-Cabanera, Nephron 71, 203-207 (1995).
Lopez-Neblina, Trans Proc vol. 27, 1883-1885 (1995).
Wallace, Novel Molecular Approaches to Anti-Inflammatory Theory, 121-129 (1995).
Vanderford, Clin. Res. 41(2), 1328-1332 (1993).
Nally, Brit. J. Pharmacol. 113, 1328-1332 (1994).
MIMS (monthly index medical supplies), publ date Dec. 27, 1995.
Langford, Arterioscl. Thromb. Vasc. Biol., vol. 16, 1, 51-55 (Jan. 1996).
Gissi-3, Lancet, 343, 1115-1122 (1994).
Dupuis, Can. J. Cardiol., vol. 6, 281-286 (1990).
Raij, Prostaglandins 54, 53-58 (1996).
Bennett, Urol. Clin. N. Amer. 17, 156-156 (1990).
Amore, Kidney Int., 47, 1507-1514 (1995).
Palmer, Nature 333, 664-666 (1988).
Ashab, Kidney Int. 47, 1515-1521 (1995).
Torfgard, Cardiov. Drugs and Ther. 8, 701-717 (1994).

Affiliated with

Also associated with

Rating

Nitric oxide donors capable of reducing toxicity from drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitric oxide donors capable of reducing toxicity from drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide donors capable of reducing toxicity from drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3711502